Company Profile
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company provides the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology
Antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. Founded in 2006 and headquartered in Daejeon, South Korea, LigaChem Biosciences was formerly known as LegoChem Biosciences, Inc. before rebranding in April 2024.